Scarica l'app Stockscreener
13.78
0.11%
-0.015
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$13.79
Aprire:
$13.74
Volume 24 ore:
466.78K
Relative Volume:
0.25
Capitalizzazione di mercato:
$1.63B
Reddito:
$260.81M
Utile/perdita netta:
$20.48M
Rapporto P/E:
105.96
EPS:
0.13
Flusso di cassa netto:
$22.67M
1 W Prestazione:
-1.68%
1M Prestazione:
+10.64%
6M Prestazione:
+25.57%
1 anno Prestazione:
+8.98%
Intervallo 1D:
$13.65
$13.84
Intervallo di 1 settimana:
$13.65
$14.63
Portata 52W:
$9.74
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Nome
Dynavax Technologies Corp
Settore
Telefono
(510) 848-5100
Indirizzo
2100 POWELL STREET, EMERYVILLE, CA
Confronta DVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
13.78 | 1.63B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
161.31 | 71.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.87 | 47.16B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.29 | 46.33B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.11 | 18.69B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
131.25 | 13.96B | 612.78M | -86.37M | -62.91M | -0.87 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Downgrade | Goldman | Neutral → Sell |
| 2024-02-01 | Iniziato | Goldman | Neutral |
| 2022-09-27 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-01-06 | Ripresa | Goldman | Buy |
| 2021-08-06 | Iniziato | Goldman | Buy |
| 2020-08-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-15 | Iniziato | Evercore ISI | Outperform |
| 2019-10-18 | Iniziato | H.C. Wainwright | Buy |
| 2019-07-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-05-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-03-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-09-25 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-07-31 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2013-11-25 | Aggiornamento | MLV & Co | Hold → Buy |
| 2013-02-25 | Downgrade | MLV & Co | Buy → Hold |
| 2012-11-16 | Reiterato | MLV & Co | Buy |
Mostra tutto
Dynavax Technologies Corp Borsa (DVAX) Ultime notizie
Dynavax at Barclays Healthcare: Strategic Growth and Market Expansion - Investing.com
Dynavax technologies’ president & COO David Novack sells $471,473 in stock - Investing.com Canada
Dynavax Activist Investor Deep Track Capital Sends Letter to Company Board, Urging Director, Strategy Changes - Marketscreener.com
Deep Track Capital pushes for board changes at Dynavax By Investing.com - Investing.com Canada
Dynavax Turns Heads As HEPLISAV-B Shows Steady Growth In The Expanding Hepatitis B Vaccine Market - RTTNews
Deep Track Capital pushes for board changes at Dynavax - Investing.com
Deep Track Capital Sends Letter to Dynavax Technologies’ Board of Directors - StockTitan
Dynavax Technologies Corp. to Host Earnings Call - ACCESS Newswire
Dynavax at TD Cowen Conference: Strategic Growth and Future Plans - Investing.com
Dynavax Signs Debt Refinancing Deals, Plans $8 Million Stock Buyback -March 06, 2025 at 07:54 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing -March 06, 2025 at 07:28 am EST - Marketscreener.com
Dynavax Announces Convertible Debt Refinancing, Common Stock Share Repurchase - Nasdaq
Dynavax stock hits 52-week high at $14.05 amid robust growth - Investing.com
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Is Dynavax Technologies Corporation (DVAX) the Best Small Cap Pharma Stock to Buy Now? - Insider Monkey
Dynavax Technologies' (NASDAQ:DVAX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
Dynavax to Participate in Upcoming Investor Conferences - Yahoo Finance
Dynavax Technologies (NASDAQ:DVAX) Upgraded to Buy at StockNews.com - Defense World
Dynavax’s SWOT analysis: hepatitis B vaccine maker’s stock poised for growth - Investing.com
Wall Street Analysts Think Dynavax Technologies (DVAX) Could Surge 81.92%: Read This Before Placing a Bet - Yahoo Finance
HC Wainwright Has Optimistic Outlook of DVAX FY2026 Earnings - Defense World
New York State Teachers Retirement System Decreases Holdings in Dynavax Technologies Co. (NASDAQ:DVAX) - Defense World
Dynavax Technologies (NASDAQ:DVAX) Hits New 12-Month High – Should You Buy? - Defense World
Dynavax Technologies (NASDAQ:DVAX) Earns Buy Rating from HC Wainwright - Defense World
Dynavax Technologies Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Deep Dive Into Dynavax Technologies Stock: Analyst Perspectives (4 Ratings) - Benzinga
DVAX stock touches 52-week high at $13.9 amid robust performance By Investing.com - Investing.com South Africa
DVAX stock touches 52-week high at $13.9 amid robust performance - Investing.com
Dynavax Technologies Corporation (NASDAQ:DVAX) Q4 2024 Earnings Call Transcript - Insider Monkey
H.C. Wainwright maintains Buy on Dynavax stock with $31 target - Investing.com
JMP raises Dynavax stock target to $33, maintains rating - Investing.com
Dynavax Technologies: Q4 Earnings Snapshot - CTPost
Dynavax Technologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies Corp (DVAX) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ... By GuruFocus - Investing.com Canada
Dynavax Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2024 - Marketscreener.com
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript - AOL
Dynavax Technologies (DVAX) Surpasses Q4 Earnings and Revenue Estimates - MSN
Earnings call transcript: Dynavax Q4 2024 shows EPS beat, revenue miss - Investing.com
High Growth Tech Stocks To Watch In February 2025 - Yahoo Finance
Dynavax Technologies climbs as investor begins proxy fight (update) - MSN
Dynavax under fire as investor targets vaccine maker’s board - The Business Journals
Dynavax Technologies (DVAX) Projected to Post Earnings on Thursday - Defense World
Palumbo Wealth Management LLC Invests $275,000 in Dynavax Technologies Co. (NASDAQ:DVAX) - MarketBeat
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors By Reuters - Investing.com
Dynavax Technologies Reiterates Board Change Already Underway -February 19, 2025 at 05:53 pm EST - Marketscreener.com
Dynavax defends strategy amid board nomination dispute - Investing.com
Deep Track Capital Nominates Four Candidates For Election To Dynavax Technologies' Board At 2025 Annual Meeting - Marketscreener.com
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors -February 19, 2025 at 08:00 am EST - Marketscreener.com
Life Sciences Investor Deep Track Launches Proxy Fight… -February 19, 2025 at 08:00 am EST - Marketscreener.com
Exclusive-Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Marketscreener.com
Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Yahoo Finance
Dynavax Technologies Corp Azioni (DVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.09%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):